Ticker Sage

Form 4 · LLY

Eli Lilly director Gabrielle Sulzberger reports an award of about 171 shares

Part of a grouped insider digest: see all related filings with totals →

Gabrielle Sulzberger, an Eli Lilly director, filed a Form 4 on Nov 17, 2026 at 4:13 PM ET reporting transactions on Nov 16, 2026.

The filing reports about 171 shares in a grant or award (code A).

After these transactions, the filing lists about 3,188 shares held directly.

Effect on holdings

Taken together, the rows reported here raised Gabrielle Sulzberger's directly held shares by 5.7%, from about 3,016 to about 3,188.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-16ACommon Stock3$1,431.67Acquired3,020Direct
2026-11-16ACommon Stock168$1,431.67Acquired3,188Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Eli Lilly company file → · More Eli Lilly filings

Disclosures

Editor holdings in LLY
The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
Last updated
Nov 17, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.